Vivozon’s Non-Opioid PainKiller Has Been Granted the FDA’s Fast Track Designation

Nov 08, 2018
By Applied Clinical Trials Editors
MMS Holdings Inc., a data-focused CRO, announced that the company has assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration for VVZ-149, a non-opioid painkiller.
 
Read the full release here.
native1_300x100
lorem ipsum